Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAlcohol is not banned while taking Mounjaro, but there are real reasons to think carefully before you pour a glass. Tirzepatide changes how your body handles food and drink, slows digestion, and affects blood sugar in ways that can make alcohol hit harder and feel worse than usual. These are prescription-only medicines, and a prescriber should factor your lifestyle into any treatment decision. The sections below walk through what actually happens when alcohol and tirzepatide meet, so you can weigh it up clearly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing the rate at which your stomach empties. In practical terms, this changes the timeline of alcohol absorption. You might feel relatively little for longer than usual, then find the alcohol arrives all at once. That delay can catch people off guard, especially on an empty stomach, which is itself more common on tirzepatide because appetite drops significantly during treatment.
There is also a blood-sugar consideration. Tirzepatide reduces glucose levels as part of how it works. Alcohol independently suppresses the liver's ability to release glucose into the bloodstream. Put the two together and the risk of blood sugar falling lower than intended rises, particularly for people who are also managing type 2 diabetes or taking other glucose-lowering medicines alongside Mounjaro. If you fall into that group, this is worth an explicit conversation with your prescriber before drinking, and our dedicated page covering whether you can drink on Mounjaro is a useful starting point for those questions.
The NHS medicines page for tirzepatide notes that patients should discuss alcohol with their clinician, particularly those using it alongside diabetes management. That guidance is grounded in the interaction above, not a blanket prohibition.
The most commonly reported side effects of Mounjaro are gastrointestinal: nausea, indigestion, reflux, and sometimes vomiting or loose stools. These tend to be most noticeable in the first few weeks of treatment or after a dose increase, though they settle for most people. Alcohol is a gastric irritant at the best of times. On Mounjaro, adding it to an already-unsettled stomach is a reliable way to bring symptoms that had been fading back to the surface.
Dizziness is another side effect that appears in the prescribing information. Alcohol produces dizziness too. The overlap is not subtle. Some people on tirzepatide also notice they feel intoxicated more quickly than they did before starting treatment, likely because reduced food intake lowers the buffer that usually slows alcohol's effect.
Hydration is a linked issue. Tirzepatide's appetite-suppressing effect can make it easier to forget to eat and drink enough across the day, and alcohol accelerates fluid loss. Our guidance on why staying hydrated matters on Mounjaro covers this in more detail, but the short version is that dehydration makes GI side effects worse and, in more serious cases, can strain the kidneys. Keeping alcohol intake low and water intake high is not just general health advice on this treatment, it is directly relevant to how well you tolerate the medicine.
None of this means a complete prohibition. The Mounjaro patient information leaflet does not instruct you to avoid alcohol entirely. What it and prescribers consistently advise is moderation, timing awareness, and not drinking on an empty stomach, three things that overlap neatly with standard safer drinking guidance anyway.
If you do drink, eating a small amount first, choosing lower-alcohol options, staying well hydrated between drinks, and avoiding drinking heavily on nights when your stomach is already unsettled are all sensible approaches. Going slowly matters more than usual because the delayed-absorption effect means your usual personal benchmarks may not apply reliably.
People who drink frequently, heavily, or who use alcohol to manage appetite or mood should mention this during their clinical consultation. It is relevant clinical information, not a reason to feel judged. A prescriber needs the full picture to assess whether Mounjaro is the right option and at what dose. You can read a broader overview of how Mounjaro works as a weight-management treatment if you want that context before your consultation.
For questions about other drinks (tea, coffee, hot drinks and their timing) our page on drinking tea on Mounjaro covers what to watch for there. And if cost is part of your decision-making, a straightforward breakdown of what private treatment involves is on our Mounjaro pricing overview.
The NHS guidance on weight-management treatment frames Mounjaro within a broader lifestyle programme. Alcohol consumption is part of that lifestyle picture, which is one reason our prescribers ask about it during the consultation process. When your pen arrives (plain packaging, tracked by DPD) your information leaflet inside will reiterate these points. Read it before your first dose.
If your situation involves PCOS, blood sugar irregularities, or hormonal factors that might interact with treatment, our page on Mounjaro and PCOS addresses some of those crossover questions. For anything specific to your own health profile, speaking directly to one of our prescribers is the most reliable route. A free consultation through our treatment page is the place to start that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.